GlassScriptPhysician profile
Michael A Oltmann
NPI 1871676403
$1,212.00
in general payments reported to CMS, 2019-2025
23 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $306 · 2020: $23.22 · 2021: $179 · 2022: $228 · 2023: $185 · 2024: $149 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $475.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $202.07 | 2019-2024 | |
| Glaxosmithkline, LLC. | $194.21 | 2020-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $94.20 | 2019-2025 | Farxiga, Breztri |
| Merck Sharp & Dohme LLC | $88.86 | 2019-2023 | Verquvo, Belsomra, Steglatro |
| Novo Nordisk INC | $88.37 | 2021-2025 | Rybelsus, Ozempic |
| Abbvie INC. | $87.94 | 2021-2023 | |
| Amgen INC. | $64.44 | 2019-2025 | Otezla, Repatha, Otezla |
| Dexcom, INC. | $55.59 | 2024-2025 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.63 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $42.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $37.58 | 2019-2022 | |
| Abbott Laboratories | $34.68 | 2022 | |
| Lilly USA, LLC | $26.32 | 2023 | Mounjaro |
| Supernus Pharmaceuticals, INC. | $21.16 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $19.14 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $17.19 | 2021 | |
| Exact Sciences Corporation | $15.29 | 2023 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $15.02 | 2022 | |
| Medtronic, INC. | $14.85 | 2025 | Intellis Adaptivestim |
| Genentech USA, INC. | $13.37 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.84 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.31 | 2022 | |
| Allergan, INC. | $11.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Oltmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.